These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6441304)

  • 1. Interaction of thromboplastin apoprotein of different tissues with concanavalin A--evidence for heterogeneous glycosylation of the human apoprotein.
    van den Besselaar AM; Bertina RM
    Thromb Haemost; 1984 Oct; 52(2):192-5. PubMed ID: 6441304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coextraction of thrombomodulin and tissue factor from human placenta: effects of concanavalin A and phospholipid environment on activity.
    Freyssinet JM; Brami B; Gauchy J; Cazenave JP
    Thromb Haemost; 1986 Feb; 55(1):112-8. PubMed ID: 3010487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modification effect of the protein component of tissue thromboplastin (factor III) on its interaction with factors VII and X].
    Zubairov DM; Baĭkeev RF; Byshevskiĭ ASh; Tersenov OA
    Biokhimiia; 1984 Jun; 49(6):971-5. PubMed ID: 6466743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of factor IX in tissue thromboplastin induced coagulation.
    van den Besselaar AM; Ram IE; Alderkamp GH; Bertina RM
    Thromb Haemost; 1982 Aug; 48(1):54-8. PubMed ID: 6982540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of bovine brain tissue factor to concanavalin A-Sepharose. Partial purification of coagulant, arylamidase, and alkaline phosphatase activities.
    Pitlick FA
    Biochim Biophys Acta; 1976 Mar; 428(1):27-34. PubMed ID: 1260023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid activation of coagulation factor III apoprotein (tissue factor)--reconstitution of the protein-membrane complex.
    Carson SD; Konigsberg WH
    Thromb Haemost; 1980 Aug; 44(1):12-5. PubMed ID: 7423440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urothromboplastin evidence for similarity between urothromboplastin and human brain thromboplastin.
    Mitterstieler G; Lechner K; Deutsch E; Margaritella P; Graninger R
    Padiatr Padol; 1983; 18(1):73-80. PubMed ID: 6682214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional consequences of mutations in Ser-52 and Ser-60 in human blood coagulation factor VII.
    Iino M; Foster DC; Kisiel W
    Arch Biochem Biophys; 1998 Apr; 352(2):182-92. PubMed ID: 9587405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetyl CoA:alpha-glucosaminide N-acetyl transferase: partial purification from human liver.
    Freeman C; Clements PR; Hopwood JJ
    Biochem Int; 1983 May; 6(5):663-71. PubMed ID: 6679731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of factor VII-Sepharose affinity chromatography in the purification of human tissue factor apoprotein.
    Bom VJ; Ram IE; Alderkamp GH; Reinalda-Poot HH; Bertina RM
    Thromb Res; 1986 Jun; 42(5):635-43. PubMed ID: 3715822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenyl--Sepharose chromatography of membrane proteins solubilized in Triton X-100.
    Carson SD; Konigsberg WH
    Anal Biochem; 1981 Sep; 116(2):398-401. PubMed ID: 7316173
    [No Abstract]   [Full Text] [Related]  

  • 12. Tissue factor revisited.
    Nemerson Y; Bach R
    Prog Hemost Thromb; 1982; 6():237-61. PubMed ID: 6762613
    [No Abstract]   [Full Text] [Related]  

  • 13. The interaction of the protein and phospholipid components of tissue thromboplastin (factor III) with the factors VII and X.
    Bjorklid E; Storm E; Osterud B; Prydz H
    Scand J Haematol; 1975 Mar; 14(1):65-70. PubMed ID: 1121648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concanavalin A inhibits tissue factor coagulant activity.
    Pitlick FA
    J Clin Invest; 1975 Jan; 55(1):175-9. PubMed ID: 233969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
    Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
    Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary procoagulant behaves as tissue factor by promoting factor VIIa-catalyzed activation of factor X.
    Kurosawa S; Matsuda M; Aoki N
    Thromb Res; 1984 Mar; 33(6):595-606. PubMed ID: 6609450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of human brain tissue factor.
    Broze GJ; Leykam JE; Schwartz BD; Miletich JP
    J Biol Chem; 1985 Sep; 260(20):10917-20. PubMed ID: 3928626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemoglobin binds melanoma cell tissue factor and enhances its procoagulant activity.
    Siddiqui FA; Francis JL
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):173-80. PubMed ID: 11943929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
    Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report of the fifth homozygous patient with factor VII Padua defect.
    Girolami A; Dal Bo Zanon R; Caenazzo A; Scattolo N
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):447-54. PubMed ID: 6194079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.